Literature DB >> 15804326

Comments to the editor on "Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model".

Jerry D Clewell, Robert W Baker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804326     DOI: 10.1111/j.1524-4733.2005.08204.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Modelling approaches: the case of schizophrenia.

Authors:  Bart M S Heeg; Joep Damen; Erik Buskens; Sue Caleo; Frank de Charro; Ben A van Hout
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.